The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO GI 2024 | Stereotactic body radiation therapy for treating colon cancer
Laura Dawson, MD, University of Toronto, Toronto, Canada, discusses stereotactic body radiation therapy (SBRT) for treating localized colorectal cancers, aiming to eradicate malignancies. Although randomized studies assessing SBRT in colon-only metastases are lacking, the potential for improved patient survival makes it a recommended option. However, SBRT should complement rather than replace other treatments such as surgical resections. In cases of oligoprogression, SBRT can precisely ablate a lesion, allowing patients to continue systemic therapies that address the remaining disease. This interview took place at 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancer Annual Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
